Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
49.24
-0.46 (-0.93%)
Feb 20, 2026, 11:51 AM EST - Market open
Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product Sales
1.82B2.11B2.96B3.03B3.11B4.96B4.90B5.01B---
Product Sales Growth
-41.52%-57.47%-39.64%-39.56%-53.40%-43.42%-51.65%-65.15%---
Grant and Collaboration
126.00M121.00M120.00M149.00M145.00M191.00M200.00M-177.00M
Grant and Collaboration Growth
-13.10%-36.65%-40.00%-15.82%-62.24%-65.52%-72.26%--78.62%
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Europe
1.20B--1.29B1.06B--1.35B2.96B3.90B5.23B6.73B--------
Europe Growth
-59.36%---66.94%-79.78%---79.90%------------
United States
1.15B1.58B1.66B1.73B2.28B1.98B1.82B1.72B--------
United States Growth
-49.58%-20.01%-8.91%0.35%17.52%-1.69%-47.44%-60.95%--------
Rest of World
653.00M802.00M798.00M810.00M1.79B2.21B2.41B3.60B--------
Rest of World Growth
-63.48%-63.63%-66.94%-77.49%-53.39%-47.31%-57.24%-50.70%--------
Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
3.13B3.48B3.82B4.34B4.54B4.83B4.85B4.78B
Research and Development Growth
-31.06%-27.93%-21.34%-9.23%-6.23%3.81%12.53%23.37%
Selling, General, and Administrative
1.02B1.06B1.07B1.11B1.17B1.29B1.45B1.52B
Selling, General, and Administrative Growth
-13.29%-17.94%-26.13%-26.75%-24.21%-11.07%12.71%29.85%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.